This educational activity will provide clinicians with insights on the most relevant clinical data for treating wet age-related macular degeneration and diabetic retinopathy/diabetic macular edema. Experts in the field will discuss ways to extend the treatment interval and individualize care in patients who suffer from these sight-threatening diseases. The desired results of this activity are to help clinicians optimize patient care by giving them information that helps them understand the place in therapy of novel and new agents that may decrease treatment burden through extending the treatment interval.
- Provider:MedEdicus, LLC
- Activity Link: https://courses.mededicus.com/content/less-more-reducing-injections-and-optimizing-vision-anti-vegf-therapy-namd-dr-and-dme-online#group-tabs-node-course-default1
- Start Date: 2024-04-01 05:00:00
- End Date: 2024-04-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 195800.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest